In a research report published today, BTIG analyst Tim Chiang reiterated a Buy rating on shares of Synthetic Biologics Inc (NYSEMKT:SYN) with a price …
In a research report published today, BTIG analyst Tim Chiang initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a Buy rating and …
In a research report published Tuesday, BTIG analyst Tim Chiang initiated coverage on shares of Synthetic Biologics Inc (NYSEMKT:SYN) with a Buy rating and a $5.00 price …
